Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) EPS (Basic): 2010-2025

Historic EPS (Basic) for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Sep 2025 value amounting to $0.25.

  • Ironwood Pharmaceuticals' EPS (Basic) rose 1150.00% to $0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.18, marking a year-over-year increase of 700.00%. This contributed to the annual value of $0.01 for FY2024, which is 100.16% up from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported EPS (Basic) of $0.25 as of Q3 2025, which was up 66.67% from $0.15 recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' EPS (Basic) registered a high of $2.42 during Q2 2021, and its lowest value of -$6.84 during Q2 2023.
  • Over the past 3 years, Ironwood Pharmaceuticals' median EPS (Basic) value was $0.01 (recorded in 2024), while the average stood at -$0.57.
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' EPS (Basic) crashed by 2,950.00% in 2023, and later skyrocketed by 1,600.00% in 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' EPS (Basic) (Quarterly) stood at $0.25 in 2021, then climbed by 28.00% to $0.32 in 2022, then crashed by 103.12% to -$0.01 in 2023, then soared by 200.00% to $0.01 in 2024, then surged by 1,150.00% to $0.25 in 2025.
  • Its EPS (Basic) was $0.25 in Q3 2025, compared to $0.15 in Q2 2025 and -$0.23 in Q1 2025.